Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulsed Field Ablation Paroxysmal Atrial Fibrillation Using a Novel Spiral Catheter Integrated With a 3-Dimensional Mapping System: The PULSTAR Study

NCT05618340 is registered in ClinicalTrials.gov with Shanghai Shangyang Medical Technology Co., Ltd. as lead sponsor.

NCT NCT05618340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulsed Field Ablation Paroxysmal Atrial Fibrillation Using a Novel Spiral Catheter Integrated With a 3-Dimensional Mapping System: The PULSTAR Study
Lead sponsor
Shanghai Shangyang Medical Technology Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
September 26, 2022
Completion date
June 1, 2024
Enrollment
149 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation